BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Oct 23, 2006
 |  BioCentury  |  Strategy

Icos chronicles

Icos chronicles

Icos chroniclesIcos (ICOS) has successfully developed one product, Cialis tadalafil, which was discovered with former partner Glaxo Wellcome and repartnered with Eli Lilly (LLY) in October 1998, when it was in Phase II. But the biotech has had a hard time getting a second product out of its pipeline, which now is all preclinical.ICOS expects to submit an sNDA for once-daily dosing of Cialis by year end. Regulatory approvals in Canada and Europe also could result in launches by the end of 2007. Cialis also is in Phase III testing for pulmonary arterial hypertension (PAH) and in Phase II for hypertension and benign...

Read the full 504 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >